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        Memory CD8 T cells represent the major 
eff  ector arm of the adaptive immune system to 
maintain long-lived protective immunity against 
intracellular bacteria, protozoa, and viruses. In 
secondary infected individuals, pathogen-specifi  c 
memory CD8 T lymphocytes are required for 
both the elimination of infected cells and host 
survival (  1  ). Upon antigen-driven reactivation, 
memory CD8 T cells diff  erentiate into cyto-
lytic, IFN-      –  , and TNF-      –  secreting eff  ector 
cells. The current paradigm is that these eff  ec-
tor functions, or at least some of them, allow 
for the control of the growth and the clearance 
of intracellular pathogens. 
  However, previous experiments using the 
Gram-positive intracellular bacterium   Listeria 
monocytogenes   have challenged this view. Mice 
primary immunized with  L. monocytogenes    develop 
long-lasting memory CD8 T cells that medi-
ate protective responses against secondary chal-
lenge with an otherwise lethal dose of bacteria 
(  2, 3  ). Upon primary immunization, mice lack-
ing perforin, CD95/CD95L, or IFN-     control 
secondary infection with WT bacteria as effi   -
ciently as WT mice, suggesting that none of these 
molecules by themselves is absolutely required 
for protection (  4  –  7  ). Although TNF-      –  defi  cient 
mice control secondary infection with WT 
bacteria as effi   ciently as WT mice (  8  ), other data 
using TNF-      –  blocking reagents argue for a 
critical role of TNF-     in the control of second-
ary   L. monocytogenes   infection (  9  –  12  ). Therefore, 
the actual role of TNF-     during secondary in-
fection needs to be clarifi  ed. 
  Other experiments have addressed which 
eff  ector functions of CD8 T cells are neces-
sary to confer protective immunity to naive re-
cipient animals that are subsequently infected 
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  Cytolysis, interferon       and tumor necrosis factor (TNF)       secretion are major effector 
mechanisms of memory CD8      T cells that are believed to be required for immunological 
protection in vivo. By using mutants of the intracellular bacterium   Listeria monocytogenes  , 
we found that none of these effector activities is suffi  cient to protect against secondary 
infection with wild-type (WT) bacteria. We demonstrated that CCL3 derived from reacti-
vated memory CD8  T cells is required for effi  cient killing of WT bacteria. CCL3 induces a 
rapid TNF-      secretion by innate infl  ammatory mononuclear phagocytic cells (MPCs), 
which further promotes the production of radical oxygen intermediates (ROIs) by both 
MPCs and neutrophils. ROI generation is the fi  nal bactericidal mechanism involved in  
L. monocytogenes   clearance. These results therefore uncover two levels of regulation of 
the antibacterial secondary protective response: (a) an antigen-dependent phase in which 
memory CD8 T cells are reactivated and control the activation of the innate immune 
system, and (b) an antigen-independent phase in which the MPCs coordinate innate im-
munity and promote the bactericidal effector activities. In this context, CCL3-secreting 
memory CD8  T cells are able to mediate   “  bystander  ”   killing of an unrelated pathogen 
upon antigen-specifi  c reactivation, a mechanism that may be important for the design of 
therapeutic vaccines. 2076 CCL3 MEMORY CD8 T CELLS ACTIVATE TNF/ROI PHAGOCYTES | Narni-Mancinelli et al.
  Cytolytic and IFN       /TNF-       –  secreting activities 
of secondary effector CD8  T cells are not suffi  cient 
to mediate protection against recall infection 
  To investigate why the   secA2   mutant failed to induce pro-
tective immunity, we have characterized the CD8 T cell 
response in groups of mice immunized with   secA2  ,   actA  , 
or WT bacteria (primary response) and further challenged the 
same groups of mice 1 mo later with WT   L. monocytogenes   
(secondary response). Spleen cells were harvested at diff  erent 
times after infection and analyzed by FACS after staining 
with LLO  91-99  /H2-K  d   tetramers, anti-CD62L, a cell surface 
marker that is lost upon activation and acquisition of eff  ector 
functions (  2, 22  ), and anti-CD127 (IL-7 receptor), a marker 
of long-living memory T cells (  23, 24  ). Mice from all groups 
exhibited similar frequencies of CD62L  low   LLO  91-99  /H2-K  d   
tetramer CD8 T cells at the peak of primary and secondary 
responses (  Fig. 2 A  ) (  25  ).   Moreover, LLO  91-99  /H2-K  d   tetramer 
CD8 T cells expanded with the same kinetics upon second-
ary challenge in mice immunized with the   secA2   and   actA   
mutant (  Fig. 2 B  ). Therefore, the absence of a protective 
  secondary response in mice immunized with the   secA2   mutant 
did not result from a decreased ability of   Listeria  -specifi  c 
memory CD8 T cells from these mice to proliferate upon 
secondary infection. We also found that mice primary im-
munized with   secA2   bacteria were not impaired in the 
generation of CD127  high   CD62L  low   eff  ector  –  memory (T  EM  ) 
cells as compared with mice immunized with WT and   actA   
bacteria (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20070204/DC1). Thus, the inability of mice 
primary immunized with   secA2   bacteria to control second-
ary infection did not result from a reduced number of T  EM   
cells (  26  ). 
  We next assessed whether   Listeria  -specifi  c CD8 T cells 
from mice immunized with the   secA2   mutant were impaired 
(  4, 6, 13, 14  ). These studies have shown that primary eff  ector 
CD8 T cells purifi  ed from IFN-      –  , TNF-      –  , perforin-, 
CD95-defi  cient, or WT infected animals confer protection 
to naive mice, albeit to a lesser extent for perforin-defi  cient 
CD8 T cells that are fi  vefold less effi   cient on a per-cell basis 
as compared with those from WT mice (  5, 15  ). Despite this 
defect, perforin-defi  cient CD8 T cells provide immunity 
equally well when transferred into WT and CD95-defi  cient 
recipient mice but fail to do so in the absence of TNF-     (  13  ). 
This latter result further suggested that bacteria elimination 
is dependent on TNF-     secretion but does not absolutely 
require CD8 T cells to express TNF-    , IFN-    , perforin, or 
CD95L. In contrast, primary eff  ector CD8 T cells purifi  ed 
from macrophage infl  ammatory protein 1     (MIP-1    /CCL3)  –
  defi  cient animals fail to confer protective immunity to naive 
mice, demonstrating that CCL3 from primary eff  ector CD8 
T cells is required for protection in this experimental setting 
(  14  ). Of note, these studies all relied on the adoptive transfer 
of primary eff  ector CD8 T cells diff  erentiating from naive 
T cells. However, very little is known on the functional ac-
tivities that need to be expressed by the secondary eff  ector 
CD8 T cells diff  erentiating from memory T cells to protect 
mice upon rechallenge. 
  Therefore, in this study, we have investigated the molec-
ular mechanisms of secondary eff  ector CD8 T cell  –  medi-
ated bacterial clearance in mice rechallenged with WT bacteria. 
To address this issue, we have taken advantage of two mu-
tants of   L. monocytogenes  ,   secA2   (    SecA2) (  16  ) and   actA   
(    ActA) (  17  ), that exhibit the same LD  50   of 10  7   in WT mice 
(  18  ). Both mutants escape primary phagocytic vacuoles and 
multiply in the cytosol of infected cells at similar rates. How-
ever, in contrast to   actA   mutants that induce long-term pro-
tective memory,   secA2   mutants do not (  18, 19  ). 
    RESULTS   
  The   secA2           mutant of   L. monocytogenes   fails to induce 
protective immunity 
  In a fi  rst set of experiments, we have compared the immune 
response induced by   secA2   and   actA   bacteria (Fig. 1). Mice 
were primary infected with 0.1  LD  50   of mutant or WT 
bacteria. Control animals were injected with PBS, heat-killed 
  L. monocytogenes   (HKLM) (  20  ), or 0.1  LD  50   of llo (    LLO) 
(  21  ), three protocols that do not induce protective memory. 
Mice were challenged 1 mo later with 10  LD  50   of WT 
bacteria and monitored for bacterial titers in the spleen and 
liver. As expected, control animals immunized with PBS or 
HKLM rapidly died and exhibited, respectively, 1,000- and 
240-fold more bacteria in the spleen and liver than mice im-
munized with WT bacteria (not depicted) that survived and 
cleared infection (  18  ). Interestingly, mice immunized with 
the   secA2   mutant or the   llo   control mutant failed to control 
secondary infection and exhibited 662- and 912-fold more 
bacteria in the spleen and liver, respectively, as compared 
with those immunized with WT or   actA   bacteria.   There-
fore, while the   actA   mutant induced protective memory, 
the   secA2   mutant did not. 
  Figure 1.     The     secA2−               mutant does not induce long-term protective 
immunity. BALB/c mice (fi  ve per group) were injected with PBS or immu-
nized with 10  9   HKLM or 0.1  LD  50   of the indicated bacteria (WT, 3  10  3 ; 
  llo    ,  5   10  8 ;   secA2      and   actA    ,  10 6  ). Mice were secondary challenged 
with 3  10  5   WT bacteria 1 mo later and killed at the indicated times 
after the infection. Data show the number of bacteria (mean  SD) in the 
spleen (empty bars) and liver (fi  lled bars) in a pool of three replicate ex-
periments. p-values were calculated between groups of mice immunized 
with   secA2      versus   actA      bacteria (with   n   	 9 mice).     JEM VOL. 204, September 3, 2007 
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frequencies of IFN-      –   and TNF-      –  secreting cells among 
CD8CD3 T cells, were similar in mice primarily immu-
nized with   secA2  ,   actA  , or WT bacteria and challenged 
with WT bacteria at early and late (2- or 3-d) time points 
(  Fig. 3 B   and not depicted). Collectively, although   Listeria  -
specifi  c reactivated memory CD8 T cells from   secA2   im-
munized mice did not confer protective immunity, they 
exhibited eff  ector functions such as cytolytic activity, expres-
sion of granzyme B, CD107a and CD95 ligand, and secretion 
of IFN-     and TNF-    . Thus, the inability of mice primary 
immunized with   secA2     bacteria to control secondary infec-
tion was neither due to ineff  ective memory CD8 T cell devel-
opment nor to impaired known eff  ector activities of these cells. 
  CCL3 secreted by secondary effector CD8  T cells 
is required for protective immunity 
  CCL3 was the only eff  ector activity that was known to be 
required for primary activated CD8 T cells to protect naive 
recipients (  14  ). We have therefore investigated whether   
in eff  ector functions such as cytolytic activity, expression of 
granzyme B, CD107a (  27  ) or CD95 ligand, and secretion of 
IFN-     or TNF-    . To measure cytolytic activity, spleen cells 
were pulsed or not with LLO  91-99  , labeled with high or low 
concentrations of CFSE, respectively, and injected into mice 
primarily immunized with   secA2  ,   actA  , or WT bacteria that 
were secondary challenged with WT bacteria. Spleen cells were 
recovered 3 h or 1 or 4 d after secondary infection and ana-
lyzed by FACS to determine the specifi  c lysis of peptide-
pulsed CFSE  high   cells. Lysis of these target cells was similar 
among all groups (  Fig. 3 A   and not depicted).   In addition, 
CD8 T cells from mice immunized with the   secA2         mu-
tant were not impaired in the expression of granzyme B, 
CD107a, and CD95 ligand (not depicted). To monitor the 
presence of IFN-  -   and TNF-      –  secreting cells, spleen cells 
from secondary challenged mice were incubated with LLO  91-99   
peptide  –  pulsed splenocytes and analyzed by intracellular cy-
tokine staining. The total numbers of IFN-      –   and TNF- 
    –  secreting CD8CD3 T cells per spleen, as well as the 
  Figure 2.     Analysis of primary and secondary CD8  T cell responses 
in mice immunized with     secA2     ,     actA     , or WT     L. monocytogenes    . 
BALB/c mice were immunized with PBS or 0.1  LD  50   of the indicated 
bacteria. (A) Mice (three per group) were either killed 8 d after the fi  rst 
immunization (top, primary) or challenged with 3  10  5   WT bacteria 30 d 
later and co-treated with 25 mg ampicillin and killed after 5 d (bottom, 
secondary). Spleen cells were analyzed by FACS upon staining with H2-K  d /
LLO  91-99   tetramers, anti-CD62L, and anti-CD8 mAbs. Data show represen-
tative FACS dot plots after gating on CD8 T cells in one out of three 
experiments. The frequency of cells in each upper quadrant is indicated. 
(B) Mice (three per group) primary immunized with PBS,   secA2 ,   actA ,  or 
WT bacteria were secondary challenged with 3  10  5   WT bacteria 30 d 
later, treated with ampicillin as above, and killed at the indicated times. 
Spleen cells were analyzed by FACS as described in A. Data show the fre-
quencies (mean  SE) of CD62L  low   H2-K d /LLO 91-99   tetramer cells among 
CD8 T lymphocytes in a representative (out of three) experiment.     
  Figure 3.     Cytolytic and IFN-      –  /TNF-      –  secreting activities of 
CD8      T cells in mice primary immunized with WT and mutants of    
L. monocytogenes.     BALB/c mice (fi  ve per group) primarily immunized with 
PBS or 0.1  LD  50   of the indicated bacteria (PBS,   secA2   ,   actA  , or WT) 
were secondary challenged 30 d later with either PBS, 3  10  5 ,  or  10 4  
(A, bottom) WT bacteria. (A) 3 h (top) or 4 d (bottom) after secondary 
challenge, animals were transferred with 10  7   CFSE low   unpulsed and CFSE  high  
LLO  91-99   peptide  –  pulsed target cells. Spleen cells from individual mice 
were analyzed by FACS 15 h later. Data show representative FACS histo-
grams in one out of three experiments. The numbers indicate the percent-
age of specifi  c lysis of peptide-pulsed CFSE  high   cells. (B) At specifi  ed times, 
spleen cells from individual mice (three per group) were restimulated in 
vitro with LLO  91-99   and analyzed by FACS for intracellular staining of IFN-    
and TNF-    . Data show the total numbers (mean  SE) of IFN-    –   (left) 
and TNF-    –   (right)  secreting  CD8  CD3    T cells per spleen in a represen-
tative (out of three) experiment.     2078 CCL3 MEMORY CD8 T CELLS ACTIVATE TNF/ROI PHAGOCYTES | Narni-Mancinelli et al.
also known to be highly dependent on the infecting dose of 
bacteria. Indeed, when mice transferred with CD8 T cells 
from secondary infected mice were challenged with 5  10  4   
Listeria  -specifi  c secondary eff  ector CD8 T cells from mice 
primary immunized with the   secA2   mutant were impaired 
in the secretion of CCL3 during secondary infection. We 
observed that the total number of CCL3-secreting CD8
CD3 T cells per spleen was twofold lower in mice immu-
nized with the   secA2   mutant or PBS as compared with those 
immunized with   actA   or WT bacteria (  Fig. 4 A  ).   Further-
more, CD8CD3 T cells from mice immunized with the 
  secA2          mutant exhibited a lower mean fl  uorescence intensity 
upon staining with anti-CCL3 serum than those from mice 
immunized with   actA   or WT bacteria (27.8 for   secA2   vs. 
44 and 62 for   actA   and WT, respectively) (  Fig. 4 A  ). Like-
wise, CD8CD3 T cells from mice immunized with the 
  secA2   mutant or PBS secreted less CCL3 when restimulated 
with LLO  91-99   than those from the two other groups (  Fig. 
4 B  ). Therefore, the secretion of CCL3 was the only known 
eff  ector function of secondary eff  ector CD8 T cells that was 
signifi  cantly altered in mice immunized with the  secA2  mutant 
as compared with those immunized with the   actA   mutant. 
  To determine whether CCL3 was required during the 
eff   ector phase of secondary protective response against   
L. monocytogenes  , mice were immunized with PBS or WT bacte-
ria, injected 30 d later with anti-CCL3 or control goat serum, 
and challenged with WT bacteria. PBS-injected mice   exhibited 
the same number of bacteria when treated with control or 
anti-CCL3 serum (  Fig. 4 C   and Fig. S2 A, which is available 
at http://www.jem.org/cgi/content/full/jem.20070204/DC1). 
In contrast, mice immunized with WT bacteria exhibited 
100- and 12-fold more bacteria in the spleen and liver, re-
spectively, when treated with anti-CCL3 serum as compared 
with control serum. Although mice injected with control 
serum survived to secondary infection, those treated with 
anti-CCL3 serum rapidly died (Fig. S3). Therefore, in vivo 
neutralization of CCL3 during secondary infection abrogated 
protective immunity. 
  To investigate if the CCL3 secreted by secondary eff  ec-
tor CD8 T cells was responsible for protection, WT CD8 
T cells from secondary challenged mice were transferred 
into CCL3/ recipient animals that received anti-CCL3 
or control serum and were subsequently infected. In this ex-
periment, 2  10  7   CD8 T cells, accounting for     40,000 
LLO  91-99  /H-2K  d    –  specifi  c CD8 T cells (  Fig. 3 B  ), were pu-
rifi  ed from WT mice and transferred into naive CCL3/ or 
control WT recipients that were treated or not with anti-
CCL3 serum and infected with 3  10  5   WT bacteria (  Fig. 4 D   
and Figs. S2 B and S4, which are available at http://www
.jem.org/cgi/content/full/jem.20070204/DC1). Protection 
was similar whether recipient mice were WT or CCL3/ 
with 4.4- (spleen) and 5.7- (liver) fold less bacteria in mice 
infused with CD8 T from secondary infected animals as 
compared with mice transferred with CD8 T cells from 
PBS-injected mice (  Fig. 4 D   and Figs. S2 B and S4). Al-
though the level of protection achieved in these latter experi-
ments was relatively low, it should be noticed that we have 
transferred 10  –  15-fold less epitope-specifi  c T cells than other 
authors (  6, 14, 28  ). Furthermore, the level of protection is 
  Figure 4.     CCL3 from CD8      T cells is required for secondary pro-
tective immunity. BALB/c mice primarily immunized with PBS or 0.1  
LD  50   of the indicated bacteria (PBS,   secA2   ,   actA       , or WT) were second-
ary challenged 30 d later with WT bacteria. (A and B) At the indicated 
times, spleen cells from individual mice were restimulated in vitro with 
LLO  91-99   peptide. (A, left) Data show a representative FACS profi  le of in-
tracellular CCL3 staining after gating on CD3     T cells. The total numbers 
(fi  lled bars) and the mean fl  uorescence intensity (empty bars) (mean  
SD) of CCL3-secreting CD8   CD3    T cells per spleen were shown 6 h after 
challenge (right). (B) Data show the concentration of CCL3 (mean  SD) 
measured by ELISA in the supernatant of restimulated cells. (A and B) 
Data result from the pool of three replicate experiments. p-values were 
calculated between groups of mice immunized with   secA2        versus   actA  
bacteria (with   n   	 7 mice). (C) Mice (three per group) primary immunized 
with PBS or WT bacteria were treated with anti-CCL3 or normal goat IgG 
control and secondary challenged. Data show the number of bacteria 
(mean  SE) in the spleen 2 d later in a representative (out of two) 
experiment. p-value was estimated accordingly to the rules of SE bars 
in the experiment shown (reference   54  ). (D) PBS-injected or primary 
immunized WT or CCL3  /   mice (8  –  12 per group) were secondary 
challenged. Purifi  ed CD8     T cells were transferred into CCL3  /   or WT mice. 
Recipient animals were further treated with anti-CCL3 or control serum 
and challenged. Data show bacteria titers (mean  SD) in the spleen 2 d 
later and result from the pool of three replicate experiments (  n   	 7). 
p-values are indicated.     JEM VOL. 204, September 3, 2007 
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bacteria (instead of 3  10  5  ), 15  –  27 less bacteria were enu-
merated in their organs as compared with those infused with 
CD8 T cells from PBS-injected animals (Fig. S5). 
  Most importantly, protection transferred to CCL3/ 
mice by WT CD8 T cells from mice immunized with WT 
bacteria was completely abrogated upon treatment with anti-
CCL3 serum, further showing that CCL3 derived from WT 
memory CD8 T cells was required for secondary protec-
tion. We also found that CCL3 from memory CD8 T cells 
accounted for the majority of the CCL3-mediated protective 
eff  ect in the liver of CCL3/ recipient mice transferred with 
WT CD8 T cells from secondary infected WT animals 
(Figs. S2 B and S4). 
  To independently demonstrate that CCL3 from second-
ary eff  ector CD8 T cells was responsible for protection, 
CCL3/ or WT control mice were primary and secondary 
infected with WT bacteria, and CD8 T cells from these 
mice were transferred into naive WT mice (  Fig. 4 D   and 
Figs. S2 B and S4). Although the transfer of WT CD8 T 
cells resulted in 4.4-fold less bacteria in the spleen, CCL3/ 
CD8 T cells only conferred a marginal protective eff  ect in 
the spleen and liver, further confi  rming a critical role of the 
CCL3 derived from secondary eff  ector CD8 T cells. Col-
lectively, our data demonstrated that CCL3, and not other 
cytokines/chemokines from reactivated memory CD8 T 
cells (and not from other cell types), is mediating secondary 
protective immunity. 
  Mononuclear phagocytes secrete TNF-      during secondary 
protective response 
Although CCL3 mediates the chemotaxis of monocytes 
and T and NK cells (  29, 30  ), this chemokine also promotes 
TNF-     secretion from macrophages in vitro (  31, 32  ). Be-
cause TNF-     has been shown to be critical for   L. monocyto-
genes   clearance and host survival during secondary infection 
(  9  –  11  ), we hypothesized that mice immunized with the   secA2      
mutant did not clear secondary infection because their CD8 
T cells were impaired in their ability to secrete CCL3 and 
subsequently to induce myeloid cells to release TNF-    . In 
agreement with previous reports, mice secondary challenged 
with WT bacteria rapidly died (Fig. S3) and exhibited 10,000- 
and 300-fold more bacteria in the spleen and liver, respec-
tively (  Fig. 5 A   and not depicted), when treated with soluble 
recombinant p75 TNF-     receptor (Enbrel) as compared 
with control animals.   TNF-     was produced by myeloid cells 
that expressed high levels of CD11b (  Fig. 5 B  ). Further 
characterization of the TNF-      –  secreting cells demonstrated 
that 90% of these cells were monocytic-derived cells (F4/
80CD11c/CD11b  med/high  Ly-6C  high  Gr1  low  ) and 10% were 
neutrophils (F4/80CD11cCD11b  high  Ly-6C  med/high  Gr1  high  ) 
(  Fig. 5 B   and not depicted). These monocytic-derived cells 
expressed MHC class II molecules, CD80, and CD86 and 
produced inducible nitric oxide synthase (iNOS) (Fig. S6, 
A and B, available at http://www.jem.org/cgi/content/full/
jem.20070204/DC1). They also contained bacterial antigens 
(  Fig. 5 C  ) as well as live replicating bacteria (not depicted) 
  Figure 5.     MPCs produce TNF-      during secondary protective re-
sponse. (A) BALB/c mice (two per group) primary immunized with PBS or 
0.1  LD  50   of WT bacteria were treated 30 d later with the soluble p75 
TNF-     receptor (Enbrel) and secondary challenged with 3  10  5   WT  bac-
teria. Data show the number of bacteria (mean  SE) in the spleen 2 d 
later in a representative (out of three) experiment. p-value was estimated 
accordingly to the rules of SE bars in the experiment shown (  54  ). (B) Mice 
(two per group) were primary immunized and secondary challenged with 
WT bacteria (B and C) or PBS (C). 10 h later, spleen cells from individual 
mice were restimulated with HKLM (B) or not (C) and analyzed by FACS 
for surface staining of CD11b, Ly-6C, CD11c, and control isotype and for 
intracellular staining of   L. monocytogenes  – derived  antigens  and  TNF-  . 
Data show representative FACS histograms after gating on the indicated 
cell population in a representative (out of three) experiment. (D) Mice 
primarily immunized with PBS,   secA2   ,   actA    , or WT bacteria were sec-
ondary challenged. At the indicated times, spleen cells from individual 
mice were restimulated with HKLM and analyzed by FACS for surface 
CD11b, Ly-6C, and intracellular TNF-    . The number (mean  SD) of TNF-    –
 producing  CD11b med/high Ly6C high   mononuclear phagocytic cells (TP-MPCs) 
per spleen is indicated and result from the pool of three replicate experi-
ments (  n   	 9). The p-values between the numbers of TP-MPCs in   secA2   - 
versus   actA     -infected mice are indicated.     2080 CCL3 MEMORY CD8 T CELLS ACTIVATE TNF/ROI PHAGOCYTES | Narni-Mancinelli et al.
(  Fig. 7 A  ).   At each time, the frequency of ROI-producing 
MPCs was 1.3- to 1.5-fold lower in mice primarily immunized 
with the   secA2   mutant or PBS as compared with those immu-
nized with   actA   or WT bacteria. In contrast, although neu-
trophils accounted for the majority (    80%) of ROI-producing 
CD11b cells (  Fig. 7, A and B,   Fig. S8, which is available at 
http://www.jem.org/cgi/content/full/jem.20070204/DC1), 
their numbers did not diff  er between mice primarily immu-
nized with   secA2  ,   actA  , or WT bacteria. In PBS-injected 
animals, however, the number of ROI-producing neutro-
phils was signifi  cantly lower compared with mice primarily 
and exhibited ultrastructural characteristics of phagocytic 
mononuclear cells (Fig. S6, C and D). They were therefore 
designated TP-MPCs for TNF-      –  producing mononuclear 
phagocytic cells.
  Both the number (  Fig. 5 D  ) and the frequency (Fig. 
S7 A, available at http://www.jem.org/cgi/content/full/
jem.20070204/DC1) of TP-MPCs in the spleen increased 
more slowly and to lower levels in mice immunized with the 
  secA2       mutant or PBS and secondary challenged as compared 
with those immunized with   actA       or WT bacteria. In con-
trast, the frequency of TNF-      –  secreting neutrophils in the 
spleen remained identical in mice immunized with   secA2       
and   actA   bacteria (not depicted). Moreover, the frequency 
of MPCs that secreted TNF-     among total MPCs was two-
fold lower at 6 and 10 h after challenge in mice immunized 
with the   secA2   mutant compared with those immunized 
with   actA−   or WT bacteria (Fig. S7 B). Therefore, the kinet-
ics of TNF-     secretion by MPCs, but not by neutrophils, 
was strongly altered in mice that received a primary immuni-
zation with the   secA2   mutant. 
  CCL3 induces MPCs to secrete TNF-      
  To assess whether CCL3 promotes TNF-     secretion by 
MPCs, we measured the number of TP-MPCs in primary 
and secondary infected mice treated or not with anti-CCL3 
serum. In mice primary immunized with WT bacteria, neu-
tralization of CCL3 before secondary infection resulted in a 
lower number of TP-MPCs in the spleen (  Fig. 6 A  , left).   In 
contrast, the number of TNF-      –  secreting neutrophils re-
mained the same (not depicted). A similar reduction in the 
number of TP-MPCs, but not neutrophils, was observed in 
mice depleted of CD8 T cells before the secondary infection 
(  Fig. 6 A  , right, and not depicted). Furthermore, recombinant 
CCL3 induced MPCs to secrete TNF-     in vitro as effi   ciently 
as HKLM (  Fig. 6 B  ). As expected, anti-CCL3 prevented 
TNF-     release, demonstrating that this eff  ect was dependent 
on CCL3. CCR1 and CCR5 are the two major receptors of 
CCL3 (  33  ). Although we could not detect the expression of 
CCR5 at the surface of TP-MPCs, 50% of these cells ex-
pressed CCR1, a result in agreement with their responsive-
ness to CCL3 (  Fig. 6 C  ). Collectively, these data support the 
hypothesis that CCL3 secreted by CD8 T cells during a sec-
ondary infection induces MPCs to rapidly release TNF-    . 
  TNF-      induces mononuclear phagocytes and neutrophils 
to produce reactive oxygen intermediates (ROIs) 
  TNF-     is an in vitro inducer of ROIs that directly allows 
  infected myeloid cells to kill bacteria (  34, 35  ). Therefore, the 
rapid release of TNF-     by MPCs may be critical for the pro-
duction of high levels of ROI and subsequent clearance of 
bacteria. To test this hypothesis, mice received a primary im-
munization with PBS, WT, or mutant bacteria and were fur-
ther challenged with WT   L. monocytogenes  . Spleen cells were 
analyzed for ROI production upon staining with anti-CD11b 
and anti  –  Ly-6C mAbs. In both PBS- and bacteria-immunized 
mice, challenge with WT bacteria induced ROI production 
  Figure 6.     CCL3 promotes TNF-     secretion by MPCs. (A) Mice pri-
mary immunized with PBS or 0.1  LD  50   of WT bacteria were treated or 
not 30 d later with the indicated blocking (anti-CCL3), depleting (anti-
CD8  
  ), or control antibodies. 10 h after secondary challenge with 3  10  5  
WT bacteria, spleen cells from individual mice were restimulated with 
HKLM and analyzed by FACS for surface expression of CD11b, Ly-6C, and 
intracellular TNF-    . Data show the number (mean  SD) of TP-MPCs per 
spleen and result from the pool of two to three replicate experiments 
(  n   	 7). p-values are indicated. (B and C) Mice were infected with 3  10  5  
WT bacteria and killed 24 h later. (B) Spleen cells from individual mice 
(fi  ve per group) were pooled, and fl  ow-sorted MPCs were incubated in 
vitro with or without HKLM or with 1     g/ml of recombinant CCL3 (endo-
toxin 1.2 pg/ml) with or without 10     g/ml anti-CCL3 serum. Cells were 
analyzed by FACS for intracellular TNF-    . Data show the frequency of 
TNF-      –  secreting cells among MPCs ( SE) and result from the pool of 
three experiments. p-value was estimated accordingly to the rules of SE 
bars from the pool of the three experiments (  54  ). (C) Spleen cells from 
individual mice (two per group) were analyzed for intracellular TNF-     and 
surface expression of CD11b, Ly-6C, CCR1 (fi  lled histograms), and CCR5 
(fi  lled histograms) or isotype control (empty histograms). Data show rep-
resentative FACS profi  les of CCR1 (left) and CCR5 (right) expression after 
gating on TP-MPCs in a representative (out of two) experiment.     JEM VOL. 204, September 3, 2007 
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MPCs and neutrophils to similar numbers as those measured 
in the PBS-immunized control group (  Fig. 7 C  ). Collec-
tively, these data reveal a causal relationship between the 
  secretion of CCL3 and the production of TNF-     by MPCs, 
and between the secretion of TNF-     and the production of 
ROIs by both MPCs and/or neutrophils. 
  ROIs produced by mononuclear phagocytes and/or 
neutrophils are necessary for bacterial clearance 
  To determine whether ROIs were required for bacterial 
clearance upon secondary infection, mice that were unable 
to generate ROIs as the result of a targeted deletion of the 
p47    phox     gene (  36  ) were immunized and challenged or not 
with WT bacteria. It has been reported that p47    phox/     mice 
are able to clear primary   L. monocytogenes   infection (  37  ). In 
contrast, upon immunization and subsequent acute challenge 
with WT bacteria, p47    phox/     mice rapidly died and exhib-
ited 3,000- and 9,000-fold more bacteria in the spleen and 
liver, respectively, as compared with WT animals (  Fig. 8   and 
Figs. S3 and S9, which are available at http://www.jem.org/
cgi/content/full/jem.20070204/DC1).   
  To further confi  rm that the lack of protection in p47   phox/     
mice actually resulted from the inability of innate cells to 
generate ROIs and not from a defective memory response, 
we compared primary and secondary CD8 T cell responses 
in WT and p47    phox/     mice. This was done using HKLM to 
restimulate CD8 T cells because p47    phox/     mice were on 
the 129 genetic background in which   Listeria   epitopes have 
not been characterized. Upon primary infection, the spleens 
of p47    phox/     mice contained similar numbers of granzyme 
B  –  expressing and IFN-      –  secreting CD8 T cells reacting 
immunized with WT bacteria (Fig. S8). Both the neutraliza-
tion of CCL3 or TNF-     and the depletion of CD8 T cells 
before the secondary challenge in mice primarily immunized 
with WT bacteria reduced the number of ROI-producing 
  Figure 7.     ROI production is induced by TNF-      during secondary 
response. (A and B) Mice primary immunized with (A) PBS or 0.1  LD  50  
of   secA2   ,   actA       , or (A and B) WT bacteria were challenged 30 d later 
with 3  10  5   WT bacteria. At the indicated times (A) or at 10 h (B) after 
secondary challenge, spleen cells from individual mice were restimulated 
with HKLM in the presence of hydroethidine. Cells were analyzed by FACS 
after staining with anti-CD11b and anti  –  Ly-6C mAbs. (A) Data show the 
number (mean  SD) of ROI-producing MPCs (left) and neutrophils 
(right) per spleen. (B) Data show a representative histogram on Ly-6C 
(gray) or control isotype (empty) after gating on ROI-producing cells. 
Numbers indicate the frequency of MPCs (CD11b  med/high Ly6C high  ) and neu-
trophils (CD11b  high Ly6C med  ) in the indicated gate. (C) Mice primary immu-
nized with PBS or WT bacteria were treated or not 30 d later with the 
indicated antibodies or sera. 10 h after secondary challenge, spleen cells 
from individual mice were treated and analyzed as above. Data show 
the number (mean  SD) of ROI-producing MPCs (top) and neutrophils 
(bottom) per spleen. (A and C) Data result from the pool of two to three 
replicate experiments. p-values are indicated. A,   n   	 7; C, right and left 
panels,   n   	 7; C, middle panel,   n   	  9.   
  Figure 8.     CCL3-producing memory CD8      T cells promote ROI gen-
eration by phagocytic cells for secondary bacterial clearance. Indi-
cated mice (three per group) were primary immunized with PBS (fi  lled 
bars) or 3  10  3   WT bacteria (empty bars). When specifi  ed, p47    phox/   
mice were reconstituted 1 mo later with 4  10  5   MPCs or 4  10  6   neu-
trophils purifi  ed from WT or p47    phox  /      mice. Mice were then treated or 
not with anti-CCL3 or anti-CD8   
    (right) and secondary challenged with 
3  10  5   bacteria. Mice were killed 2 d later, and the number of bacteria in 
the liver (mean  SE) was measured. Data are representative of one out 
of two to three experiments. p-values were estimated accordingly to the 
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the production of ROIs by MPCs and neutrophils, leading to 
subsequent clearance of the bacteria (  Fig. 9  ).   
  Secondary effector   Listeria  -specifi  c CD8      T cells mediate 
CCL3-dependent bystander killing of the intracellular 
parasite   Leishmania major   
  One important prediction of our fi  ndings is that CCL3-
secreting memory CD8 T cells should promote an antigen-
independent antimicrobial eff  ector phase by innate immune 
cells upon antigen-specifi  c restimulation. Therefore, we have 
postulated that any ROI-sensitive pathogen would be killed 
upon restimulation of memory cells in a bystander fashion. 
To test this hypothesis, BALB/c mice were immunized with 
against HKLM as those from WT mice. Upon secondary 
  infection, these numbers were three- to fi  vefold increased as 
expected for a recall response (Fig. S10, available at http://
www.jem.org/cgi/content/full/jem.20070204/DC1). Most 
importantly, this memory response was similar in p47    phox/     
and WT mice, suggesting that the lack of protective immu-
nity in secondary infected p47    phox/     mice did not result from 
defective CD8 T cell memory. 
  To independently confi  rm that ROIs were critical for 
secondary protection against   L. monocytogenes  , we used a dif-
ferent experimental approach in which WT BALB/c mice 
primarily immunized with WT bacteria were treated with 
a superoxyde scavenger (  38  ) before secondary challenge to 
neutralize the oxidative burst in vivo (Fig. S11, available 
at http://www.jem.org/cgi/content/full/jem.20070204/DC1). 
As compared with untreated animals, mice treated with a 
superoxyde scavenger exhibited 1,073- and 230-fold more 
bacteria in the spleen and liver, respectively. Therefore, col-
lectively, these results on two distinct genetic backgrounds 
demonstrate that the generation of ROIs is required for both 
bacterial clearance and survival of secondary infected mice. 
  To further clarify the role of MPCs and neutrophils in 
ROI production and bacteria elimination, 4  10  5   MPCs 
or 4  10  6   neutrophils from WT or p47    phox/     naive mice 
were transferred into p47    phox/     mice primary immunized 
with WT bacteria or PBS and secondary challenged with 
WT bacteria (  Fig. 8   and Fig. S9). Mice reconstituted with 
MPCs from WT mice exhibited 170- and 10-fold less bacte-
ria in the spleen and liver, respectively, than those recon-
stituted with MPCs from p47    phox/     mice. Similarly, mice 
reconstituted with neutrophils from WT mice exhibited 
1,000- and 80-fold less bacteria in the spleen and liver, re-
spectively, than those reconstituted with neutrophils from 
p47    phox/     mice. Also, PBS-immunized p47    phox/     recipient 
mice failed to clear infection with WT bacteria even when 
reconstituted with MPCs or neutrophils from WT mice. 
Collectively, these results show that both MPCs and neutro-
phils from WT mice, but not those from p47    phox/−     mice, 
were able to restore a protective secondary response when 
transferred into p47    phox/     mice. Because protection was 
only observed in p47    phox/     mice primary immunized with 
WT bacteria, these data strongly suggested that the presence 
of memory cells was required to activate ROI production 
and bacteria killing. 
  We next verifi  ed that the restoration of protective im-
munity by MPCs or neutrophils in secondary challenged 
p47    phox/     mice was dependent on CCL3 and CD8 T cells. 
p47    phox/     mice were primary immunized with WT bacteria, 
reconstituted with MPCs or neutrophils from WT mice, 
treated or not with anti-CCL3 or with anti-CD8, and sec-
ondary challenged with WT bacteria. Neutralization of CCL3 
or CD8 T cell depletion prevented bacterial clearance both 
in mice reconstituted with MPCs or neutrophils (  Fig. 8   and 
Fig. S9). Therefore, secretion of CCL3 by reactivated mem-
ory CD8 T cells during secondary infection induces the ac-
celerated release of TNF-     by MPCs that in turn promotes 
  Figure 9.     Schematic representation of memory CD8      T cell  –  mediated 
antibacterial immunity. The cartoon shows (A) release of CCL3 by sec-
ondary effector CD8     T cells, binding of CCL3 to its receptor CCR1 at 
the surface of MPC that results in MPC activation, (B) secretion of TNF-    
by MPCs that leads to neutrophil and MPC activation, and (C) TNF-    –
  induced production of ROIs by neutrophils and MPCs, and subsequent 
bacteria killing.     JEM VOL. 204, September 3, 2007 
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secondary eff  ector CD8 T cells from mice immunized with 
  secA2   bacteria did not secrete CCL3 as compared with those 
from mice immunized with   actA   or WT bacteria. Although 
these diff  erences were modest, they were signifi  cant and re-
producible. How could relatively small diff  erences account for 
such a dramatic eff  ect in protection? At least two explanations 
can account for these observations. First, the CCL3-secreting 
cells that were present in mice immunized with   actA   or WT 
bacteria may be localized in strategic areas of the spleen that 
are critical for the development of protective immunity. A 
small diff  erence in the number of CCL3-secreting cells could 
therefore have a major impact on the outcome of the recall 
infection. Second, several cytokines such as TNF-     (  40  ), 
IFN-    /  
   (  41  ), or IL-12 (  42  ) have been shown to be biologi-
cally active and/or to exert a distinct eff  ect above a specifi  c 
threshold. Likewise, small diff  erences in the amount of secreted 
CCL3 could lead to a distinct biological response, i.e., pro-
tective versus nonprotective.
  CCL3 is an infl  ammatory molecule that activates macro-
phages to secrete TNF-     (  31, 32  ) and exhibits chemotactic 
activities on several cell types (  29, 30  ). Neutralization of 
CCL3 in protected animals reduces both the total number of 
MPCs in the spleen and the number of these cells that secrete 
TNF-    . It remains unclear whether CCL3 induces activation 
or recruitment of MPCs or both. We have found (a) that re-
combinant CCL3 induces MPCs to secrete TNF-     in vitro, 
and (b) that the total number of MPCs in the spleen is 
identical in mice immunized with   secA2   bacteria as com-
pared with those immunized with   actA   bacteria, whereas 
the frequency of TP-MPCs among MPCs is twofold lower. 
Thus, although it remains to be determined whether CCL3 
also promotes MPC recruitment, it does activate MPCs to 
secrete TNF-    . 
  We and others have demonstrated that TNF-     blockade 
using mAbs or soluble receptor prevents protective immunity 
after secondary infection, therefore demonstrating a critical 
role of this cytokine in this process (  9, 10  ). These results are 
in apparent contrast to those obtained in TNF-/ mice 
or in mice exhibiting TNF-      –  defi  cient macrophages and 
neutrophils that are able to develop long-term protective 
immunity (  8  ). How can these data be reconciled? Regarding 
TNF-/ mice, it is well established that these animals do 
not regulate properly the development and the organization 
of splenic follicular architecture and exhibit defects in their 
lymphoid organs and germinal centers (  43, 44  ). Furthermore, 
these mice are unable to regulate the homeostasis and the ex-
tent and duration of infl  ammatory processes. Therefore, it is 
conceivable that the development of protective immunity in 
TNF-    / mice results from compensatory mechanisms that 
do not refl  ect what is happening in WT mice. 
  In a recent study, Grivennikov et al. (8) have taken ad-
vantage of the lysozyme M (lys-M) promoter to generate 
mice in which macrophages and neutrophils did not express 
TNF-    . These mice were protected against secondary infec-
tion, further suggesting that lys-M  –  expressing cells were not 
required for protection. We have found that at least 50% of 
WT   L. monocytogenes   and infected 3 wk later with the intra-
cellular ROI-sensitive   L. major   promastigotes (  39  ). Parasite-
containing mice were challenged 2 wk later either with   
L. monocytogenes   or LPS-matured DCs pulsed or not with the 
dominant   Listeria  -derived LLO  91-99   peptide (  Fig. 10   and not 
depicted).   Animals challenged with   L. monocytogenes   or peptide-
pulsed DCs exhibited 10,000- and 1,000-fold less   L. major   
parasites in their spleen than those injected with PBS and 
control LPS-matured DCs, respectively. This dramatic de-
crease in parasite burden was completely abrogated upon in-
jection of a CCL3-neutralizing, but not of a control, serum 
(not depicted). Therefore antigen-driven restimulation of   
L. monocytogenes    –  specifi  c memory CD8 T cells can induce 
antigen-independent CCL3-mediated bystander killing of an 
unrelated intracellular parasite. 
    DISCUSSION   
Several studies have demonstrated that neither cytolytic ac-
tivity nor secretion of IFN-     or TNF-     by CD8 T cells was 
absolutely required for resistance to   L. monocytogenes   in mice 
(  4, 6, 13  ). In contrast, CCL3-defi  cient CD8 T cells isolated 
from primary infected mice did not confer protective immu-
nity upon transfer into recipient mice (  14  ). Although this 
suggested that secretion of CCL3 by primary eff  ector CD8 
T cells is required for protection, it was not known whether 
CCL3 derived from secondary eff  ector CD8 T cells could 
confer protection to primary infected animals. In this study, 
we show that protection conferred by reactivated memory 
CD8 T cells depends on their ability to secrete CCL3. This 
was independently shown by experiments in which CD8 T 
cells from WT or CCL3/ mice were injected into CCL3/ 
mice, as well as in neutralization experiments using anti-
CCL3 mAb. In agreement with these data, we found that 
  Figure 10.     CCL3 from secondary effector CD8  +   T cells mediate 
bystander killing in vivo. BALB/c mice (three per group) primarily immu-
nized with 0.1  LD  50   of WT   L. monocytogenes   ( Lm  ) or control PBS were 
infected i.v. 3 wk later with the intracellular parasite   L. major   (2   10  6 /
mouse). 2 wk later, mice were treated or not with anti-CCL3 serum and 
injected with 3  10  5   WT   Lm ,  2   10  7   LPS-matured splenic DCs pulsed 
with the   Lm -derived  LLO 91-99   dominant epitope, or PBS (control). Spleens 
were harvested 2 d later, and cells were incubated in   L. major   growth 
medium (M199). (A) Schematic representation of the experimental proto-
col. (B) The number of live parasites per well ( SD) was determined after 
4 d of culture. Data show the results of the pool of two replicate experi-
ments (with   n   	 6 mice). p-value is indicated.     2084 CCL3 MEMORY CD8 T CELLS ACTIVATE TNF/ROI PHAGOCYTES | Narni-Mancinelli et al.
and   actA    −      bacteria escape from phagocytic vacuoles, multiply 
in cytosol, and exhibit the same LD  50  , these mutants never-
theless exhibit distinct defects.   ActA    −      bacteria cannot mobi-
lize actin (  17, 19  ).   SecA2    −      bacteria lack an ATPase that is 
critical for an auxiliary protein secretion system important for 
the secretion of at least 17 bacterial proteins (  16  ). It is con-
ceivable that egress in the cytosol of one or more of the 
SecA2-dependent proteins is required for the diff  erentiation 
of bacteria-specifi  c naive CD8 T cells into fully functional 
memory cells. 
  The measure of cytolytic IFN-      –   and TNF-      –  secreting 
activity of memory CD8 T cells is widely used to predict 
the ability of an immunized individual to develop a protec-
tive immune response. Although these activities may accu-
rately refl  ect the ability of the host to resist to a secondary 
challenge in some infectious diseases, this study suggests that 
it may not always be the case and that another eff  ector activ-
ity such as CCL3 secretion could be an important marker to 
predict vaccine effi   cacy. Importantly, we have shown that it 
is also possible to induce, in an antigen-dependent fashion, a 
CCL3-mediated bystander killing of an unrelated pathogen, 
a mechanism that could potentially be used for therapeutic 
immunologically based protocols. In fact, some microbial in-
fections cannot be treated with conventional medications any-
more because the pathogens have become resistant to multiple 
drugs. For instance, this is the case for some strains of   Myco-
bacterium tuberculosis   or   Staphylococcus aureus  . If such patients 
were previously vaccinated with attenuated   L. monocytogenes   
bacteria, it should be possible to specifi  cally reactivate the 
CCL3-secreting memory CD8 T cells to mediate the by-
stander elimination of multidrug-resistant pathogens without 
the need of any other medication. We believe that taking 
advantage of this mechanism may have important therapeutic 
implications for curative medicine. 
  MATERIALS AND METHODS 
  Mice 
  6  –  8-wk-old BALB/cByJ female mice (Janvier Laboratories) were used in all 
experiments unless otherwise indicated. p47    phox/     mice (  36  ) were obtained 
from European Mouse Mutant Archive, and CCL3  /   (  51  ) were obtained 
from The Jackson Laboratory. Aged-matched 129S2/SvPasCrl control mice 
were purchased from Charles River Laboratories. lys-M GFP-expressing 
knock-in mice (lys-M-GFP  +/  −   ) (  45  ) were provided by T. Graf (Albert Einstein 
College of Medicine, New York, NY). L9.6 TCR transgenic mice have 
been described (  2  ). p47    phox      /  , CCL3  /  , lys-M  –  GFP  /  , and L9.6 mice 
were housed and bred in our specifi  c pathogen-free animal facility. All mice 
were used in accordance with Animal Care and Use regional C  ô  te d  ’  Azur 
Committee procedures. 
  Bacteria and parasites 
  The   L. monocytogenes   10403s WT strain was used in all experiments. The 
  actA  ,   llo      , and   secA2       mutant strains were on the 10403s WT strain back-
ground and have been described. The WT,   actA      ,   llo      , and   secA2       strains ex-
hibit an LD  50   of 3  10  4  , 5  10  9  , 10  7  , and 10  7  , respectively, in BALB/c mice 
(  16, 19, 21  ). HKLM was prepared as described previously (  2  ). All bacteria 
were prepared from clones grown from organs of infected mice. Stocks of 
bacteria were kept frozen at   −  80  °  C. DsRed-expressing   L. major   promasti-
gotes (World Health Organization strain WHOM/IR/-/173) (  52  ) were 
grown in M199 medium containing 20% FCS. 
the MPCs that are the main source of TNF-     during second-
ary infection do not express lys-M in the lys-M  –  GFP/ 
knock-in mouse (Fig. S12, available at http://www.jem.org/
cgi/content/full/jem.20070204/DC1) (  45  ). Therefore, this 
cell-specifi  c TNF-     knockout strategy did not completely 
abrogate the production of TNF-     from all CD11b-expressing 
cells, further providing an explanation for the survival of these 
mice after a secondary challenge. 
  Our results also highlight that the fi  ne-tuning of TNF-     
production is crucial for effi   cient control of secondary bac-
terial growth. Although TNF-     is produced by several cell 
types including CD8 T cells, this is the TNF-     derived from 
non  –  CD8 T cells that is required for secondary protection 
(  12  ). As mentioned before, 80  –  90% of TNF-      –  secreting 
cells during secondary infection are MPCs, and depletion of 
CD8 T cells or neutralization of CCL3 abrogated both the 
release of TNF-     by MPCs and mice resistance. This result, 
together with the lys-M experiments described above, strongly 
suggests that TNF-     produced by MPCs, but not by other 
cells, is critical for secondary protective immunity. 
  A recent study has identifi  ed an infl  ammatory subset of 
DCs that produce large amounts of TNF-     and are necessary 
for mice survival upon primary infection. These cells were 
designated Tip-DCs for TNF-    /iNOS-producing DCs (  46  ). 
Tip-DCs and MPCs express the same DC-specifi  c surface 
markers, and both produce iNOS that generates reactive ni-
tric intermediates (RNIs). However, in contrast to Tip-DCs, 
MPCs express the macrophage marker F4/80, contain live 
and dead bacteria, and produce ROIs. It remains to be deter-
mined whether Tip-DCs and MPCs are related or not. 
  A previous study has suggested that RNIs are not neces-
sary for bacterial clearance during a secondary response (  47  ). 
Our results further show that ROI generation is the fi  nal 
bacteria killing eff  ector mechanism required for secondary 
protection. In contrast, RNIs, but not ROIs, are necessary 
for bacterial clearance and mice survival during primary 
  infection, (  48  ). RNI depends on iNOS synthesis that is regu-
lated at the transcriptional level (  49  ). The generation of ROIs 
is dependent on phosphorylation of the cytosolic regulatory 
protein p47    phox    . This event leads to activation of the NADPH 
oxidase, a TNF-      –  induced activity that is far more rapid than 
the regulation at the transcriptional level (  50  ). All the mecha-
nisms involved in this regulation loop are rapid, including 
secretion of CCL3 by memory CD8 T cells, secretion of 
TNF-     by MPCs, phosphorylation of p47    phox     upon binding 
of TNF-     to its surface receptor, activation of NADPH oxi-
dase, and ROI production. The ability of TNF-     to induce 
both MPCs and neutrophils to produce ROIs results in an 
amplifi  cation loop that allows rapid clearance of high doses 
of bacteria, a mechanism that does not occur in naive mice 
because of the lack of memory CD8 T cells. 
  The aim of this study was to elucidate the molecular and 
cellular events that orchestrate the control of bacterial growth 
in secondary infected mice. However, the molecular signals 
that are required for the priming of fully functional memory 
CD8 T cells remain to be identifi  ed. Although both   secA2    −      JEM VOL. 204, September 3, 2007 
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normal goat IgG, and staining was revealed using goat anti  –  rabbit Alexa 647 
mAb. For intracellular staining of CCL3, cells were incubated for 20 min 
on ice in FACS buff  er containing anti-CCL3 goat polyclonal antibodies, 
and staining was revealed using donkey anti  –  goat Alexa 647 mAbs. In all 
cases, cells were washed, fi  xed for 30 min in 1% paraformaldehyde FACS 
buff  er, and analyzed on a FACSCalibur cytofl  uorometer (Becton Dickinson). 
When indicated, cells were sorted on a FACSVantage SE cell sorter 
(Becton Dickinson). 
  Assay for CCL3 secretion 
  Supernatants were analyzed for CCL3 content by ELISA using the DuoSet 
ELISA kit (R  &  D Systems). The sensitivity of the assay was 2 pg/ml. 
  In vivo killing assay 
  Spleen cells were pulsed or not with 1 nM LLO  91-99   for 1 h at 37  °  C. Pulsed 
and unpulsed cells were incubated for 10 min at 37  °  C in PBS containing 
5 or 0.5     M CFSE, respectively. Cells were washed in PBS, and 10  7   of 
peptide-pulsed and 10  7   of unpulsed cells were co-injected i.v. into recipient 
mice. Mice were killed 15 h later, and spleen cells were analyzed by FACS. 
Cytolytic activity against peptide-pulsed target cells was determined by mea-
suring the frequency of CFSE  high   and CFSE  low   cells and by calculating the 
percentage of specifi  c lysis using the following formula: 100   −   ([(% peptide 
pulsed in infected/% unpulsed in infected) / (% peptide pulsed in un-
infected/% unpulsed in uninfected)]  100) (  53  ). 
  In vivo neutralization and depletion experiments 
  For neutralization of TNF-    , mice were injected with 1.5 mg of soluble p75 
TNF-     receptor (Enbrel) i.p. and infected 1 d later. For superoxyde neutral-
ization (MnTBAP; A.G. Scientifi  c, Inc.), mice were injected with 10     g/g 
of body weight (  38  ) and infected 1 d later. For neutralization of CCL3, mice 
were treated with 75     g anti-CCL3 or goat IgG control i.v at the time of 
the secondary infection and 24 h later. For depletion of CD8 T cells, mice 
were injected three times daily with 100     g of the anti-CD8  
   H-35 mAb 
or its control isotype i.p., and then infected 1 d after. 
  Cell transfer experiments 
  CD8  T cell transfers.     WT or CCL3  /   mice were PBS injected or pri-
mary immunized with WT bacteria and secondary challenged 1 mo later with 
3  10  5   WT bacteria. Mice were killed 6 h later, and splenic CD8 T cells 
were negatively enriched using 5     g/ml of homemade anti  –  MHC-II (MKD6), 
anti-CD4 (GK1.5), anti-B220 (RA3), and anti-CD19 (1D3) mAbs in 5% FCS 
RPMI 1640 containing 5% FCS and 2     g/ml Golgi Plug. CD8 T cells were 
further fl  ow cell sorted, and 20  10  6   cells (    40,000 LLO  91-99  /H2-K  d    –  specifi  c 
CD8 T cells) with a purity of 
90% were transferred per naive WT or 
CCL3  /   recipients. Mice were subsequently treated with anti-CCL3 or con-
trol goat serum and infected with 3  10  5   or 5  10  4   WT bacteria. 
  Monocyte and neutrophil transfers.     Naive WT or p47  phox/   mice were 
killed, and spleen and bone marrow cells were fi  rst positively enriched 
using anti-CD11b  –  specifi  c MACS beads (Miltenyi Biotec) according to the 
manufacturer  ’  s standard protocol and further fl  ow cell sorted based on their 
ex  pression of CD11b and Ly-6C cell surface markers, with monocytic-
derived cells being CD11b  med/high  Ly-6C  high   and neutrophils being CD11b  high 
Ly-6C  med/high  . PBS-injected or WT-immunized p47  phox/   mice were 
reconstituted with 4  10  5   MPCs (purity 
87%) or 4  10  6   neutrophils 
(purity 
93%). 1 d later, mice were treated with anti-CCL3 or control goat 
serum and infected with 3  10  5   WT bacteria. 
  DC transfers.     Spleen cells of naive BALB/c mice were positively enriched 
using anti-CD11c  –  specifi  c MACS beads (Miltenyi Biotec) according to the 
manufacturer  ’  s standard protocol. For LPS stimulation, cells were plated at 
10  6   cells/ml in RPMI 1640 medium containing 20% FCS supplemented 
with 0.1     g/ml LPS (Sigma-Aldrich). 20 h later, cells were washed and 
pulsed with 1     M of the LLO  91-99   peptide for 1 h, and 20  10  6   of these 
peptide-pulsed mature DCs were transferred per recipient mouse. 
  Infection of mice and measure of protective immunity 
and mice survival 
  For   L. monocytogenes   infections, bacteria were grown to a logarithmic phase 
(OD  600   	 0.05  –  0.15) in broth heart infusion (BHI) medium (Sigma-Aldrich) 
diluted in PBS and injected i.v. into the lateral tail vein. In all experiments, 
mice were primary immunized with a 0.1  LD  50   of bacteria (3  10  3  ). Sec-
ondary infections were performed 1 mo later with 10  LD  50   of WT bacteria 
(3  10  5  ) except when specifi  ed otherwise. To measure bacterial titers in the 
spleen and liver, organs were harvested and dissociated on metal screens in 
10 ml of 0.1% Triton X-100 (Sigma-Aldrich). Serial dilutions were performed 
in the same buff  er, and 100 l was plated onto BHI media plates. Mice sur-
vival was monitored twice a day. 
  For   L. major   infections, mice were injected with PBS or infected with 0.1  
LD  50   of WT bacteria and infected i.v with 2  10  6   stationary phase promasti-
gotes 3 wk later. Mice were secondary challenged after 2 wk with WT bacte-
ria or LPS-matured DCs pulsed with the   Listeria  -derived LLO  91-99   peptide 
and co-treated or not with anti-CCL3. To determine the parasite burden in 
the spleens, organs were harvested 48 h after challenge and dissociated on ny-
lon screens in 5 ml of M199 medium containing 20% FCS, 100 g/ml peni-
cillin, and 100 U/ml streptomycin. Serial dilutions were performed in the 
same buff  er, and cells were incubated in fl  at-bottom 96-well plates at 27  °  C for 
3  –  6 d. The number of parasite was determined using a FACS Array (Becton 
Dickinson) to monitor the red fl  uorescence of the live parasite. 
  Antibodies and reagents 
  The following mAbs were purchased from BD Biosciences: anti  –  CD8     (53  –
  6.7)-FITC, -PE,   –  peridinin chlorophyll protein (PcP), or -allophycocyanin 
(APC), anti  –  CD3    -FITC (145-2C11), anti  –  Ly-6C  –  FITC (AL-21), anti  –
  CD107a-FITC (1D4B), anti  –  CD11c-PE (HL3), anti  –  CD11b-PE, -PcP, or 
-APC (M1/70); CD80-PE (16-10A1), anti  –  CD86-PE (GL1), anti  –  I-A  d    –  PE 
(AMS-32.1), anti  –  CCR5-PE (C34-3448), anti  –  CD62L-APC (MEL-14), 
anti  –  CD127-APC (A7R34), anti  –  IFN-      –  APC (XMG1-2), anti  –  TNF-      –
  APC (MP6-XT22), and control rat IgG  1   mAb. Anti  –  NOS-2 (M-19) poly-
clonal rabbit and anti  –  CCR-1 (C-20) antibodies were purchased from Santa 
Cruz Biotechnology, Inc. Difco Listeria O rabbit polyserum was purchased 
from Fischer. Goat and donkey anti  –  rabbit Alexa 647 and CFSE were pur-
chased from Invitrogen. Goat polyclonal anti-CCL3 antibody and recombi-
nant mouse CCL3 (rCCL3) was purchased from R  &  D Systems. Endotoxin 
content of 1     g rCCL3 from Gram-negative bacteria was 1.2 pg/ml as 
determined using the Limulus Amebocyte Lysate QCL-1000 (Cambrex). 
PE-conjugated LLO  91-99  /H2-K  d   tetramers were obtained from the National 
Institutes of Health (NIH) tetramer core facility. 
  Cell suspensions 
  Organs were cut in small pieces and incubated at 37  °  C for 20 min in HBSS 
medium (Invitrogen) containing 4,000 U/ml collagenase I (Invitrogen) and 
0.1 mg/ml DNase I (Roche). Red blood cells were lysed for 2  –  3 min in 170 
mM NH  4  Cl, 17 mM Tris HCl, pH 7.4. All steps of intracellular CCL3 stain-
ing as well as purifi  cation of CD8 T cells for transfer experiments were per-
formed in the presence of 2     g/ml Golgi plug (BD Biosciences). 
  Antibody staining and fl  ow cytometry 
  Cells were stained with the specifi  ed antibodies in 100     l of PBS containing 
0.5% BSA (FACS buff  er). For intracellular staining, splenocytes were incu-
bated at 37  °  C and 5% CO  2   for 3  –  4 h in RPMI 1640 (Invitrogen) containing 
5% FCS and 2     g/ml Golgi Plug (BD Biosciences) with or without 5  10  8   
HKLM/ml, 1 nM LLO  91-99   (Mimotopes), or 1     g/ml of recombinant mouse 
CCL3 (R  &  D Systems). Cells were incubated for 20 min on ice with the in-
dicated cell surface marker mAbs, fi  xed in 1% paraformaldehyde FACS buf-
fer for 20 min on ice, and permeabilized for 30 min in 1XPerm/Wash (BD 
Biosciences). For intracellular staining of TNF-     or IFN-    , cells were incu-
bated for 20 min on ice in FACS buff  er containing anti  –  IFN-    , anti  –  TNF-    , 
or control rat IgG  1  . For intracellular staining of iNOS or   Listeria   antigens, 
cells were incubated for 20 min on ice in FACS buff  er containing anti-iNOS 
rabbit polyclonal, anti-  Listeria   Difco   Listeria   O rabbit polyserum, or control 2086 CCL3 MEMORY CD8 T CELLS ACTIVATE TNF/ROI PHAGOCYTES | Narni-Mancinelli et al.
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  Electron microscopy 
  Flow-sorted CD11b  med/high  Ly-6C  high   cells were fi  xed with 1.6% glutaralde-
hyde in 100 mM phosphate buff  er, pH 7.5. Cells were incubated at 4  °  C in 
100 mM cacodylate buff  er, pH 7.0, containing 1% osmium tetroxyde. Cel-
lular pellets were washed with distilled water and incubated for 2 h with 
0.5% uranyl acetate buff  er at room temperature in the dark. Cells were 
washed in water, and pellets were dehydrated in increasing acetone series 
and embedded in epoxy resins. Blocks were thin-sectioned using standard 
procedures and contrasted for the observation on an electron microscope 
(CM12; Philips). 
  Assay for the production of ROIs 
  5-10  10  6   splenocytes were incubated for 3 h at 37  °  C and 5% CO2 in 5% 
FCS RPMI 1640 with 5  10  8   HKLM/ml and 160 M hydroethidine (Poly-
sciences). Hydroethidine is oxidized by ROIs in red fl  uorescent ethidium 
bromure, which allows for the detection of ROI-producing cells. Cells were 
washed in FACS buff  er and stained for expression of cell surface markers. 
  Statistical analysis 
  Statistical signifi  cance was calculated using an unpaired Mann-Whitney test 
and Instat software. All p-values of 0.05 were considered signifi  cant and 
are referred to as such in the text. In experiments for which we did not have 
  n   
 6 subjects to run a Mann-Whitney test, we have applied the rules of SE 
bars (  54  ) and accordingly provided an estimated p-value for all panels shown 
in the study. 
  Online supplemental material 
  Fig. S1 shows the frequency of tetramer    CD127    CD62L     (T  EM  ) and 
tetramer    CD127    CD62L     (T  CM  ) ( SE) among CD8     T cells. Fig. S2 
shows that CCL3 from CD8     T cells is required for protection against sec-
ondary infection in the liver. Fig. S3 shows the survival kinetics of WT mice 
treated or not with anti  –  TNF-     or anti-CCL3 and of p47    phox/     mice dur-
ing secondary infection. Fig. S4 shows that CCL3 from CD8     T cells is re-
quired for secondary protective immunity in the spleen and liver (as in Fig. 
4 D and Fig. S2), but data are expressed in the percentage of the maximum 
protective eff  ect achieved by transferring WT CD8     T cells from secondary 
infected animals. Fig. S5 demonstrates that the protection achieved by trans-
ferring WT CD8     T cells increases when recipient animals are challenged 
with lower numbers of bacteria (5  10  4   instead of 3  10  5  ). Fig. S6 pro-
vides a phenotypic characterization of the TP-MPCs and shows that they are 
infected using electron microscopy. Fig. S7 shows the frequencies of TP-
MPCs in the spleen and among total MPCs during secondary infection in 
mice primarily immunized with PBS or 0.1  LD  50   of the indicated bacteria. 
Fig. S8 monitors the numbers of ROI-producing MPCs and neutrophils in 
primary and secondary infected mice. Fig. S9 shows that the CCL3-produc-
ing memory CD8     T cells promote ROI generation by phagocytic cells for 
secondary bacterial clearance in the liver of infected mice. Fig. S10 shows the 
number of granzyme B  –  expressing and IFN-      –  secreting CD8     T cells in 
WT and p47    phox/     129 mice after primary and secondary infection. Fig. S11 
demonstrates that ROIs are required for mediating secondary protection 
against   L. monocytogenes   infection in WT mice treated with an O  2       scavenger 
before secondary challenge. Fig. S12 provides an analysis of lys-M expression 
in TP-MPCs during secondary infection. The online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20070204/DC1. 
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